HealthcareServices

Optical Genome Mapping Industry Growth Insights: Revenue Forecast to 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the optical genome mapping market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Optical Genome Mapping Market covering 2026–2035?_x000D_

The market size for optical genome mapping has expanded significantly in recent years. It is projected to increase from $0.23 billion in 2025 to $0.29 billion in 2026, registering a compound annual growth rate (CAGR) of 29.4%. Historically, this growth has been fueled by factors such as the limitations of next generation sequencing in detecting large structural variants, a rise in genomic research funding, the increasing prevalence of genetic disorders, a growing demand for advanced cytogenetic techniques, and technological advancements in imaging and DNA labeling._x000D_

_x000D_

The optical genome mapping market is projected to experience substantial expansion over the next few years. It is expected to achieve a market size of $0.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 25.9%. This anticipated growth during the forecast period stems from several factors, including the increasing integration of optical genome mapping (OGM) into clinical laboratories, rising investments in precision medicine initiatives, the growing adoption of automated genomic analysis platforms, expanding applications in oncology and hematological malignancies, and the declining costs associated with genomic analysis technologies. Prominent trends observed for this period encompass the growing adoption of optical genome mapping in structural variant detection, its increased utilization in rare disease and cancer research, a rising demand for high-resolution long-read genomic analysis, the expansion of OGM applications within clinical diagnostics, and a growing preference for the complementary use of OGM alongside sequencing technologies._x000D_

_x000D_

#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp_x000D_

_x000D_

Which Drivers Are Impacting The Competitive Landscape Of The Optical Genome Mapping Market?_x000D_

The rising demand for precision medicine is anticipated to fuel the expansion of the optical genome mapping market moving forward. Precision medicine represents a healthcare approach that tailors medical treatments and prevention strategies to individual characteristics such as genetic makeup, lifestyle, and environment. The need for precision medicine is propelled by factors including the increasing prevalence of chronic diseases, breakthroughs in genomic technologies, rising investment and funding, and patient desire for personalized care. optical genome mapping enhances the effectiveness of precision medicine by delivering a comprehensive and precise understanding of genomic alterations linked to various diseases. For instance, in February 2024, as per the Personalized Medicine Coalition, a US-based non-profit organization, the FDA sanctioned 16 new personalized therapies for patients with rare diseases in 2023, an increase from six in 2022. Thus, the growing requirement for precision medicine is driving the growth of the optical genome mapping market._x000D_

_x000D_

What Segments Are Identified Within The Structure Of The Optical Genome Mapping Market?_x000D_

The optical genome mapping market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Instruments, Consumables And Reagents, Software, Services_x000D_

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications_x000D_

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices_x000D_

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells_x000D_

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software_x000D_

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services_x000D_

_x000D_

Which Market Trends Are Opening Growth Opportunities In The Optical Genome Mapping Market?_x000D_

Leading companies in the optical genome mapping (OGM) market are primarily focused on advancing technology, such as developing OGM-based laboratory-developed tests (LDTs) for genome-wide structural variant detection, with the goals of improving diagnostic accuracy, increasing workflow efficiency, and reducing the need for multiple traditional cytogenetic tests. An OGM-based LDT operates by using ultra-long, high-molecular-weight DNA molecules, which are fluorescently labeled and then linearized in nanochannels, enabling high-resolution imaging. This allows for the identification of insertions, deletions, translocations, and repeat expansions across the genome, capabilities often missed by short-read sequencing or microarrays. For example, in March 2023, Bionano Laboratories, a CLIA-certified U.S. subsidiary of Bionano Genomics, introduced the OGM Dx Postnatal Whole Genome SV test. This product facilitates genome-wide detection of structural variants in patients experiencing developmental disorders, intellectual disability, autism spectrum disorder, epilepsy, or undiagnosed genetic conditions. It integrates high-resolution OGM with variant calling within a single-test workflow, thereby minimizing the necessity for multiple classical cytogenetic assays and providing more rapid, comprehensive diagnostic insights._x000D_

_x000D_

Which Key Market Players Are Investing In Expansion And Innovation Within The Optical Genome Mapping Market?_x000D_

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics_x000D_

_x000D_

#Access The Complete Report For Deeper Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report_x000D_

_x000D_

Which Regions Are Projected To Dominate The Optical Genome Mapping Market In The Coming Years?_x000D_

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request Your Customized Optical Genome Mapping Market Research Report for Competitive Advantage:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company#_x000D_

_x000D_

Genomics Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report_x000D_

_x000D_

Digital Genome Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/digital-genome-global-market-report_x000D_

_x000D_